MDC Partners Inc. (NASDAQ: MDCA; TSX: MDZ.A) ("MDC Partners" or the "Company") announced today that Scott Kauffman, Chairman and Chief Executive Officer, and David Doft, Chief Financial Officer,...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

Rhythm Pharmaceuticals, Inc. announced today the results from a proof-of-concept, Phase 1b clinical trial assessing the safety and efficacy of setmelanotide (RM-493), the company's novel...

Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the presentation of clinical data featuring the use of its Precision Cancer MonitoringSM (PCM) platform...

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) today announced that top-line renal results from the EMPA-REG OUTCOME® study (compound empagliflozin,...